title: Pre-emptive analgesic effect of lornoxicam in mandibular third molar surgery: a prospective, randomized, double-blind clinical trial.
abstract: The aim of this study was to establish whether the pre-emptive use of lornoxicam (16mg) in third molar surgery ensures successful postoperative analgesia and reduces rescue analgesic intake when compared to postoperative application, and in comparison with placebo. Ninety patients were split randomly into three groups: group A received lornoxicam 60min before surgery and placebo 60min after surgery; group B received placebo 60min before surgery and lornoxicam 60min after surgery; group C received placebo 60min before surgery and placebo 60min after surgery. Postoperative pain was recorded on a visual analogue scale and on a numerical rating scale at 1, 2, 4, 6, 8, 12, and 24h after surgery. The patients recorded total dose of paracetamol intake during the 24h after the procedure. The efficacy of postoperative analgesia was greater in lornoxicam groups when compared to the placebo group; there was no difference between the two lornoxicam groups (A and B). Patients in group C took their first rescue analgesic dose earlier after surgery than patients in the two lornoxicam groups. The average dose of paracetamol taken in group C was 1000mg, while it was500 mg in the lornoxicam groups.
authors.affiliation: Department of Oral Surgery, Jagiellonian University Medical College, Krakow, Poland. Electronic address: imojsa@yahoo.com.
authors.forename: I M
authors.initials: IM
authors.lastname: Mojsa
authors.affiliation: Department of Oral Surgery, Jagiellonian University Medical College, Krakow, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Stypulkowska
authors.affiliation: Department of Oral Surgery, Jagiellonian University Medical College, Krakow, Poland.
authors.forename: P
authors.initials: P
authors.lastname: Novak
authors.affiliation: Department of Oral Surgery, Jagiellonian University Medical College, Krakow, Poland.
authors.forename: K
authors.initials: K
authors.lastname: Lipczynski
authors.affiliation: Department of Integrated Dentistry, Jagiellonian University Medical College, Krakow, Poland.
authors.forename: K
authors.initials: K
authors.lastname: Szczeklik
authors.affiliation: Department of Oral Surgery, Jagiellonian University Medical College, Krakow, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Zaleska
mesh_terms: D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008334:Mandible / Q000601:surgery; D008875:Middle Aged; D008964:Molar, Third / Q000601:surgery*; D010147:Pain Measurement; D010149:Postoperative Pain / Q000517:prevention & control*; D010894:Piroxicam / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011446:Prospective Studies; D014095:Tooth, Impacted / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; C059451:lornoxicam
keywords: NSAID; analgesic; lornoxicam.; pain; third molar surgery